These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 26099352)

  • 41. Topical AC-11 abates actinic keratoses and early squamous cell cancers in hairless mice exposed to Ultraviolet A (UVA) radiation.
    Mentor JM; Etemadi A; Patta AM; Scheinfeld N
    Dermatol Online J; 2015 Apr; 21(4):. PubMed ID: 25933088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
    Stockfleth E
    J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of actinic keratoses and squamous cell carcinoma.
    Salasche SJ
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 2):4-7. PubMed ID: 10607349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of proliferating cell nuclear antigen as a surrogate end point biomarker in actinic keratosis and adjacent, normal-appearing, and non-sun-exposed human skin samples.
    Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Levine N; Grogan T
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):343-8. PubMed ID: 9162299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Actinic keratosis].
    Heppt MV; Steeb T; Szeimies RM; Berking C
    Hautarzt; 2020 Aug; 71(8):588-596. PubMed ID: 32468291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
    Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
    Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Actinic keratoses, actinic field change and associations with squamous cell carcinoma in renal transplant recipients in Manchester, UK.
    Wallingford SC; Russell SA; Vail A; Proby CM; Lear JT; Green AC
    Acta Derm Venereol; 2015 Sep; 95(7):830-4. PubMed ID: 25784002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
    Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
    Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current perspective on actinic keratosis: a review.
    Siegel JA; Korgavkar K; Weinstock MA
    Br J Dermatol; 2017 Aug; 177(2):350-358. PubMed ID: 27500794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical findings using ingenol mebutate gel to treat actinic keratoses.
    Martin G; Swanson N
    J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S39-48. PubMed ID: 23228305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emerging drugs for actinic keratosis.
    Ulrich M; Drecoll U; Stockfleth E
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Karyometry of nuclei from actinic keratosis and squamous cell cancer of the skin.
    Ranger-Moore J; Bozzo P; Alberts D; Einspahr J; Liu Y; Thompson D; Stratton S; Stratton MS; Bartels P
    Anal Quant Cytol Histol; 2003 Dec; 25(6):353-61. PubMed ID: 14714302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ingenol Mebutate and the Treatment of Actinic Keratosis.
    Heron CE; Feldman SR
    J Drugs Dermatol; 2021 Jan; 20(1):102-104. PubMed ID: 33400406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Actinic keratoses: non-invasive diagnosis for field cancerisation.
    Ulrich M; Maltusch A; Röwert-Huber J; González S; Sterry W; Stockfleth E; Astner S
    Br J Dermatol; 2007 May; 156 Suppl 3():13-7. PubMed ID: 17488401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
    Ulrich M; Alarcon I; Malvehy J; Puig S
    Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma.
    Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The actinic dysplasia syndrome - diagnostic approaches defining a new concept in field carcinogenesis with multiple cSCC.
    Dejonckheere G; Suppa M; Del Marmol V; Meyer T; Stockfleth E
    J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():16-20. PubMed ID: 31833608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
    Schauder DM; Kim J; Nijhawan RI
    JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detecting field cancerization using a hyperspectral imaging system.
    Neittaanmäki-Perttu N; Grönroos M; Tani T; Pölönen I; Ranki A; Saksela O; Snellman E
    Lasers Surg Med; 2013 Sep; 45(7):410-7. PubMed ID: 24037822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptomic Study on Human Skin Samples: Identification of Two Subclasses of Actinic Keratoses.
    Dubois-Pot-Schneider H; Khairallah G; Brzenczek C; Plénat F; Marchal F; Amouroux M
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.